MicroRNA expression profile in intrauterine hypoxia‑induced pulmonary hypoplasia in rats

Huo,Huiyi; Luo,Ziqiang; Wang,Mingjie; Yu,Xiaohe; Liao,Zhengchang; Zhou,Xiaocheng; Yue,Shaojie

doi:10.3892/etm.2014.1796

MicroRNA expression profile in intrauterine hypoxia‑induced pulmonary hypoplasia in rats

Authors:
- Huiyi Huo
- Ziqiang Luo
- Mingjie Wang
- Xiaohe Yu
- Zhengchang Liao
- Xiaocheng Zhou
- Shaojie Yue
View Affiliations

Affiliations: Department of Neonatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Physiology, Xiangya School of Medicine, Central South University, Changsha, Hunan 410008, P.R. China, Department of Neonatology, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 410007, P.R. China
Published online on: June 20, 2014 https://doi.org/10.3892/etm.2014.1796
Pages: 747-753

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypoxia is necessary for fetal development; however, excess hypoxia is detrimental. The mechanisms underlying the effects of hypoxia on lung development remain unclear, although important roles of microRNAs (miRNAs) during lung development have recently been established. However, the effect on lung development at an miRNA expression level, following changes in oxygen tension, have not yet been studied. In the present study, pregnant rats were exposed to a fraction of inspired oxygen of 10.5 or 21% for two days on gestation day 19, following which the body weight, lung wet weight, radial alveolar count (RAC) and mean linear intercept (Lm) of the newborn pups were analyzed on postnatal day 1. To define the role of miRNAs during lung development following intrauterine hypoxia exposure, the miRNA expression pattern was profiled using a miRNA microarray. The newborn rats in the hypoxic group exhibited statistically significant decreases in body weight, lung weight and the RAC, as well as a marked increase in the Lm. A total of 69 miRNAs were identified to have significant changes in expression, including 55 upregulated and 14 downregulated miRNAs. Quantitative polymerase chain reaction was used to validate the microarray results of six selected miRNAs. Therefore, the results indicated that late gestation intrauterine hypoxia exposure may cause lung injury and miRNAs may play important roles in this process.

View Figures

View References

1	Habek D, Hodek B, Herman R and Habek JC: Fetal hypoxia-etiology and pathophysiology of hypoxic damage. Lijec Vjesn. 122:82–89. 2000.(In Croatian).
2	Jensen A and Berger R: Fetal circulatory responses to oxygen lack. J Dev Physiol. 16:181–207. 1991.
3	de Grauw TJ, Myers RE and Scott WJ: Fetal growth retardation in rats from different levels of hypoxia. Biol Neonate. 49:85–89. 1986.PubMed/NCBI
4	Mach M, Dubovický M, Navarová J, Brucknerová I and Ujházy E: Experimental modeling of hypoxia in pregnancy and early postnatal life. Interdiscip Toxicol. 2:28–32. 2009. View Article : Google Scholar : PubMed/NCBI
5	Sayed D and Abdellatif M: MicroRNAs in development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
6	Kajekar R: Environmental factors and developmental outcomes in the lung. Pharmacol Ther. 114:129–145. 2007. View Article : Google Scholar : PubMed/NCBI
7	Yang Y, Kai G, Pu XD, Qing K, Guo XR and Zhou XY: Expression profile of microRNAs in fetal lung development of Sprague-Dawley rats. Int J Mol Med. 29:393–402. 2012.PubMed/NCBI
8	Khoshgoo N, Kholdebarin R, Iwasiow BM and Keijzer R: MicroRNAs and lung development. Pediatr Pulmonol. 48:317–323. 2013. View Article : Google Scholar
9	Huang Y: National prevalence survey of PIH. Chinese Journal of Obstetrics and Gynecology. 26:2–5. 1991.
10	Giles BL, Suliman H, Mamo LB, Piantadosi CA, Oury TD and Nozik-Grayck E: Prenatal hypoxia decreases lung extracellular superoxide dismutase expression and activity. Am J Physiol Lung Cell Mol Physiol. 283:L549–L554. 2002.PubMed/NCBI
11	Mortola JP, Xu LJ and Lauzon AM: Body growth, lung and heart weight, and DNA content in newborn rats exposed to different levels of chronic hypoxia. Can J Physiol Pharmacol. 68:1590–1594. 1990. View Article : Google Scholar : PubMed/NCBI
12	Al-Hasan YM, Evans LC, Pinkas GA, Dabkowski ER, Stanley WC and Thompson LP: Chronic hypoxia impairs cytochrome oxidase activity via oxidative stress in selected fetal Guinea pig organs. Reprod Sci. 20:299–307. 2013. View Article : Google Scholar : PubMed/NCBI
13	Williams AE, Moschos SA, Perry MM, Barnes PJ and Lindsay MA: Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev Dyn. 236:572–580. 2007. View Article : Google Scholar : PubMed/NCBI
14	Sessa R and Hata A: Role of microRNAs in lung development and pulmonary diseases. Pulm Circ. 3:315–328. 2013. View Article : Google Scholar : PubMed/NCBI
15	Truog WE, Xu D, Ekekezie II, et al: Chronic hypoxia and rat lung development: analysis by morphometry and directed microarray. Pediatr Res. 64:56–62. 2008. View Article : Google Scholar : PubMed/NCBI
16	Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP and Abman SH: Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol. 287:L344–L351. 2004. View Article : Google Scholar
17	Bertero T, Robbe-Sermesant K, Le Brigand K, et al: microRNAs target identification: lessons from hypoxamiRs. Antioxid Redox Signal. Feb 3–2014.(Epub ahead of print).
18	Anderson RN: Deaths: leading causes for 2000. Natl Vital Stat Rep. 50:1–85. 2002.PubMed/NCBI
19	Waters KA and Machaalani R: Role of NMDA receptors in development of respiratory control. Respir Physiol Neurobiol. 149:123–130. 2005. View Article : Google Scholar : PubMed/NCBI
20	Larson JE and Thurlbeck WM: The effect of experimental maternal hypoxia on fetal lung growth. Pediatr Res. 24:156–159. 1988. View Article : Google Scholar : PubMed/NCBI
21	Shi W, Xu J and Warburton D: Development, repair and fibrosis: what is common and why it matters. Respirology. 14:656–665. 2009. View Article : Google Scholar : PubMed/NCBI
22	McQueston JA, Cornfield DN, McMurtry IF and Abman SH: Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation. Am J Physiol. 264:H865–H871. 1993.PubMed/NCBI
23	Grosshans H and Slack FJ: Micro-RNAs: small is plentiful. J Cell Biol. 156:17–21. 2002. View Article : Google Scholar : PubMed/NCBI
24	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
25	Lu Y, Okubo T, Rawlins E and Hogan BL: Epithelial progenitor cells of the embryonic lung and the role of microRNAs in their proliferation. Proc Am Thorac Soc. 5:300–304. 2008. View Article : Google Scholar : PubMed/NCBI
26	Ahn HW, Morin RD, Zhao H, et al: MicroRNA transcriptome in the newborn mouse ovaries determined by massive parallel sequencing. Mol Hum Reprod. 16:463–471. 2010. View Article : Google Scholar : PubMed/NCBI
27	Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X and Quigg RJ: MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 22:4126–4135. 2008. View Article : Google Scholar : PubMed/NCBI
28	Chang SJ, Weng SL, Hsieh JY, Wang TY, Chang MD and Wang HW: MicroRNA-34a modulates genes involved in cellular motility and oxidative phosphorylation in neural precursors derived from human umbilical cord mesenchymal stem cells. BMC Med Gen. 4:652011. View Article : Google Scholar
29	Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM and Hu RM: MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol. 36:181–188. 2009. View Article : Google Scholar : PubMed/NCBI
30	Zhang H, Liu X, Chen S, et al: Tectorigenin inhibits the in vitro proliferation and enhances miR-338^* expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis. J Ethnopharmacol. 131:165–173. 2010. View Article : Google Scholar : PubMed/NCBI
31	Chan SY and Loscalzo J: MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle. 9:1072–1083. 2010. View Article : Google Scholar : PubMed/NCBI
32	Chan YC, Banerjee J, Choi SY and Sen CK: miR-210: the master hypoxamir. Microcirculation. 19:215–223. 2012. View Article : Google Scholar : PubMed/NCBI